Sickle Cell Anemia Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by Application
1.3.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2017-2028)
2.2 Sickle Cell Anemia Therapeutics Growth Trends by Region
2.2.1 Sickle Cell Anemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Sickle Cell Anemia Therapeutics Market Dynamics
2.3.1 Sickle Cell Anemia Therapeutics Industry Trends
2.3.2 Sickle Cell Anemia Therapeutics Market Drivers
2.3.3 Sickle Cell Anemia Therapeutics Market Challenges
2.3.4 Sickle Cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue
3.1.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Anemia Therapeutics Revenue
3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2021
3.5 Sickle Cell Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Sickle Cell Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Sickle Cell Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Sickle Cell Anemia Therapeutics Breakdown Data by Application
5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sickle Cell Anemia Therapeutics Market Size (2017-2028)
6.2 North America Sickle Cell Anemia Therapeutics Market Size by Type
6.2.1 North America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
6.3 North America Sickle Cell Anemia Therapeutics Market Size by Application
6.3.1 North America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country
6.4.1 North America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2017-2028)
7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type
7.2.1 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application
7.3.1 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country
7.4.1 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle Cell Anemia Therapeutics Market Size (2017-2028)
9.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Type
9.2.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Application
9.3.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Country
9.4.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Company Details
11.1.2 Emmaus Medical Business Overview
11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction
11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.1.5 Emmaus Medical Recent Developments
11.2 Addmedica
11.2.1 Addmedica Company Details
11.2.2 Addmedica Business Overview
11.2.3 Addmedica Sickle Cell Anemia Therapeutics Introduction
11.2.4 Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.2.5 Addmedica Recent Developments
11.3 Gamida Cell
11.3.1 Gamida Cell Company Details
11.3.2 Gamida Cell Business Overview
11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction
11.3.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.3.5 Gamida Cell Recent Developments
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction
11.4.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.4.5 GlycoMimetics Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Anemia Therapeutics Introduction
11.5.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Sickle Cell Anemia Therapeutics Introduction
11.6.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 Global Blood Therapeutics
11.7.1 Global Blood Therapeutics Company Details
11.7.2 Global Blood Therapeutics Business Overview
11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.7.5 Global Blood Therapeutics Recent Developments
11.8 Micelle BioPharma
11.8.1 Micelle BioPharma Company Details
11.8.2 Micelle BioPharma Business Overview
11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Introduction
11.8.4 Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.8.5 Micelle BioPharma Recent Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Details
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction
11.9.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.9.5 Bluebird Bio Recent Developments
11.10 Prolong Pharmaceuticals
11.10.1 Prolong Pharmaceuticals Company Details
11.10.2 Prolong Pharmaceuticals Business Overview
11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.10.5 Prolong Pharmaceuticals Recent Developments
11.11 Modus Therapeutics
11.11.1 Modus Therapeutics Company Details
11.11.2 Modus Therapeutics Business Overview
11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction
11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.11.5 Modus Therapeutics Recent Developments
11.12 Sangamo Biosciences
11.12.1 Sangamo Biosciences Company Details
11.12.2 Sangamo Biosciences Business Overview
11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction
11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.12.5 Sangamo Biosciences Recent Developments
11.13 Bioverativ
11.13.1 Bioverativ Company Details
11.13.2 Bioverativ Business Overview
11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction
11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.13.5 Bioverativ Recent Developments
11.14 Imara
11.14.1 Imara Company Details
11.14.2 Imara Business Overview
11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction
11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.14.5 Imara Recent Developments
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
11.15.5 Ironwood Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2017-2022)
Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2023-2028)
Table 11. Sickle Cell Anemia Therapeutics Market Trends
Table 12. Sickle Cell Anemia Therapeutics Market Drivers
Table 13. Sickle Cell Anemia Therapeutics Market Challenges
Table 14. Sickle Cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Sickle Cell Anemia Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2021)
Table 18. Ranking of Global Top Sickle Cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle Cell Anemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Sickle Cell Anemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Emmaus Medical Company Details
Table 63. Emmaus Medical Business Overview
Table 64. Emmaus Medical Sickle Cell Anemia Therapeutics Product
Table 65. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Emmaus Medical Recent Developments
Table 67. Addmedica Company Details
Table 68. Addmedica Business Overview
Table 69. Addmedica Sickle Cell Anemia Therapeutics Product
Table 70. Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Addmedica Recent Developments
Table 72. Gamida Cell Company Details
Table 73. Gamida Cell Business Overview
Table 74. Gamida Cell Sickle Cell Anemia Therapeutics Product
Table 75. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Gamida Cell Recent Developments
Table 77. GlycoMimetics Company Details
Table 78. GlycoMimetics Business Overview
Table 79. GlycoMimetics Sickle Cell Anemia Therapeutics Product
Table 80. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 81. GlycoMimetics Recent Developments
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Sickle Cell Anemia Therapeutics Product
Table 85. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Pfizer Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Sickle Cell Anemia Therapeutics Product
Table 90. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. Global Blood Therapeutics Company Details
Table 93. Global Blood Therapeutics Business Overview
Table 94. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product
Table 95. Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Global Blood Therapeutics Recent Developments
Table 97. Micelle BioPharma Company Details
Table 98. Micelle BioPharma Business Overview
Table 99. Micelle BioPharma Sickle Cell Anemia Therapeutics Product
Table 100. Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 101. Micelle BioPharma Recent Developments
Table 102. Bluebird Bio Company Details
Table 103. Bluebird Bio Business Overview
Table 104. Bluebird Bio Sickle Cell Anemia Therapeutics Product
Table 105. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Bluebird Bio Recent Developments
Table 107. Prolong Pharmaceuticals Company Details
Table 108. Prolong Pharmaceuticals Business Overview
Table 109. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 110. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Prolong Pharmaceuticals Recent Developments
Table 112. Modus Therapeutics Company Details
Table 113. Modus Therapeutics Business Overview
Table 114. Modus Therapeutics Sickle Cell Anemia Therapeutics Product
Table 115. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Modus Therapeutics Recent Developments
Table 117. Sangamo Biosciences Company Details
Table 118. Sangamo Biosciences Business Overview
Table 119. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product
Table 120. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 121. Sangamo Biosciences Recent Developments
Table 122. Bioverativ Company Details
Table 123. Bioverativ Business Overview
Table 124. Bioverativ Sickle Cell Anemia Therapeutics Product
Table 125. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 126. Bioverativ Recent Developments
Table 127. Imara Company Details
Table 128. Imara Business Overview
Table 129. Imara Sickle Cell Anemia Therapeutics Product
Table 130. Imara Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 131. Imara Recent Developments
Table 132. Ironwood Pharmaceuticals Company Details
Table 133. Ironwood Pharmaceuticals Business Overview
Table 134. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product
Table 135. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
Table 136. Ironwood Pharmaceuticals Recent Developments
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Blood Transfusion Features
Figure 3. Pharmacotherapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Child Case Studies
Figure 7. Adult Case Studies
Figure 8. Sickle Cell Anemia Therapeutics Report Years Considered
Figure 9. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2021 VS 2028
Figure 12. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2021
Figure 13. Global Top Sickle Cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2021
Figure 15. North America Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
Figure 17. North America Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
Figure 18. North America Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
Figure 19. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
Figure 25. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Share by Region (2017-2028)
Figure 35. China Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
Figure 45. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
Figure 51. Turkey Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 55. Addmedica Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 56. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 57. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 59. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 60. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 61. Micelle BioPharma Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 62. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 63. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 64. Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 65. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 66. Bioverativ Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 67. Imara Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 68. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Industry Market Size
